114 related articles for article (PubMed ID: 6610401)
1. Perfluorocarbon infusion in bleeding patients refusing blood transfusions.
Waxman K; Tremper KK; Cullen BF; Mason GR
Arch Surg; 1984 Jun; 119(6):721-4. PubMed ID: 6610401
[TBL] [Abstract][Full Text] [Related]
2. Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness.
Brown AS; Reichman JH; Spence RK
Ann Plast Surg; 1984 May; 12(5):449-53. PubMed ID: 6742725
[TBL] [Abstract][Full Text] [Related]
3. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.
Tremper KK; Cullen BF
Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719
[TBL] [Abstract][Full Text] [Related]
4. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
[TBL] [Abstract][Full Text] [Related]
5. Perfluorocarbons as blood substitutes.
Waxman K
Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615
[TBL] [Abstract][Full Text] [Related]
6. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
Stefaniszyn HJ; Wynands JE; Salerno TA
J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
[TBL] [Abstract][Full Text] [Related]
7. Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion.
Keipert PE
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):381-94. PubMed ID: 7493059
[TBL] [Abstract][Full Text] [Related]
8. Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients.
Spence RK; McCoy S; Costabile J; Norcross ED; Pello MJ; Alexander JB; Wisdom C; Camishion RC
Crit Care Med; 1990 Nov; 18(11):1227-30. PubMed ID: 1699704
[TBL] [Abstract][Full Text] [Related]
9. Fluosol-DA as a red-cell substitute in acute anemia.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
[TBL] [Abstract][Full Text] [Related]
10. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
[TBL] [Abstract][Full Text] [Related]
11. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
Suyama T; Yokoyama K; Naito R
Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
[TBL] [Abstract][Full Text] [Related]
12. Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass.
Holman WL; Spruell RD; Ferguson ER; Clymer JJ; Vicente WV; Murrah CP; Pacifico AD
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):774-85. PubMed ID: 7564446
[TBL] [Abstract][Full Text] [Related]
13. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
Tremper KK; Anderson ST
Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
[TBL] [Abstract][Full Text] [Related]
14. Effect of perfluorochemical (PFC) emulsion on acute carbon monoxide poisoning in rats.
Yokoyama K
Jpn J Surg; 1978 Dec; 8(4):342-52. PubMed ID: 732057
[TBL] [Abstract][Full Text] [Related]
15. Is hemoglobin level alone a reliable predictor of outcome in the severely anemic surgical patient?
Spence RK; Costabile JP; Young GS; Norcross ED; Alexander JB; Pello MJ; Atabek UM; Camishion RC
Am Surg; 1992 Feb; 58(2):92-5. PubMed ID: 1550312
[TBL] [Abstract][Full Text] [Related]
16. Fluosol: therapeutic failure in severe anemia.
Kale PB; Sklar GE; Wesolowicz LA; DiLisio RE
Ann Pharmacother; 1993 Dec; 27(12):1452-4. PubMed ID: 8305774
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss.
Police AM; Waxman K; Tominaga G
Crit Care Med; 1985 Feb; 13(2):96-8. PubMed ID: 3967511
[TBL] [Abstract][Full Text] [Related]
18. [The anti-ischemic action of a perfluorocarbon emulsion (PFCE) on the canine myocardium].
Ladilov IuV; Islamov BI; Vorob'ev SI; Ivanitskiĭ GR
Biull Eksp Biol Med; 1991 Feb; 111(2):139-42. PubMed ID: 1906759
[TBL] [Abstract][Full Text] [Related]
19. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
[TBL] [Abstract][Full Text] [Related]
20. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
